NATAMYCIN|NISIN|PULLULAN|PGA

Freda Biotechnology was founded and began to produce the four biological materials in 2008. Currently our production capacity reaches 200 tons for each product per year (including Freda brand and OEM brands). In 2016, our export value amounted to 10 million USD.

Freda plays an important role at the global market of biological ingredients depending on the reliable quality and high cost-effectiveness, resulted from:
# strong research strength of our R&D platform, or the key state laboratory “Shandong Academy of Pharmaceuticals” (sdaps.cn);
# GMP grade workshops, and proficient and mature pharm grade production and quality control;
# highly customized solutions. 

Meet us at:
FIE (08.0S55) | Frankfurt | Nov. 28~30, 2017.